Search PubMed⌕ Search

PubMed · 10709803

Setting specifications for non-normally distributed data.

Abstract

In this paper, we focus on estimating an upper specification for non-normally distributed data. Cornish-Fisher expansions were exploited for derivations of the method. The method was applied for upper specification calculations of two particle-size data sets, and simulation studies were also performed to demonstrate the accuracy of the approximations. The method was also used to calculate the critical values for delta(min) for the Anderson-Hauck test for equivalence using bootstrap samplings. The main advantage of the method is in calculating specifications with limited data.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Saranadasa. 2000. Setting specifications for non-normally distributed data.. https://doi.org/10.1081/bip-100101015

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The influence of model drugs on the preparation of pellets by extrusion/spheronization: II. Spheronization parameters.

Five drug-models, 4-parahydroxybenzoic acid (4HBA), methyl (MBA), propyl (PBA) and butyl (BBA) paraben and propyl gallate (PG), all of similar chemical nature, were mixed in different proportions (50-73.7%) with microcrystalline cellulose (MCC) (26.3-50%) plus various levels of water (26.9-50.0%). The wet powder mass was extruded and spheronized under standard conditions. The pellets produced were evaluated in terms of their median diameter, their modal size range, the % within a given size range (0.7-1.7 mm) and their shape factor. For the majority of formulations, all drug models, except 4HBA, produced pellets. This material only had two combinations of excipients that produced acceptable pellets. For all the model drugs, two combinations of formulations could be identified; (1) a combination, which produced pellets from all the model drugs and (2) a combination, which was too wet to produce pellets with any of the model drugs. Between these two extremes, whether pellets could be made and their quality varied with the model drug. Cluster analysis was able to divide the formulations into 4 clusters. In cluster 1 all the model drugs produced pellets except 4HBA; in cluster 2 all drugs produced pellets except MBA; in cluster3, pellets were produced with PBA, BBA and PG while MBA produced agglomerates and 4HBA was too dry; in cluster 4, MBA and BBA produced pellets, PBA produced agglomerates while 4HBA was too dry to pelletise and PG too dry to extrude. The five drug models showed different relationships between the median pellet size and drug-load and initial water content in the formulation. Cluster analysis indicated that, the level of water and type of model drug were the most significant factors in determining the pellet size. Three clusters could be identified, but the response to water content was drug dependent. It was not possible to identify a relationship between the force required to extrude the wet mass and the ability to produce good pellets nor their median size. All the products, which could be classified as good pellets, when produced, had a shape factor that can be considered to be indicative of a spherical shape. The most consistent material, in terms of spheronization, as represented by median diameter, size range and roundness, was propyl gallate (PG), which throughout all the formulations produced an almost constant value for shape factor and median pellet size, which in the majority of cases fell within a limited pellet size.

Chemistry, Pharmaceutical↗

Rapid quantitative determination and assessment of insulin in oil formulation by micellar electrokinetic capillary chromatography.

A rapid, simple and precise micellar electrokinetic capillary chromatrography (MEKC) with diode array detector had been developed to the determination of insulin in oil formulation. As the micelle-forming ampholytic surfactant, Labrasol was chosen for the separation and analysis of the hydrophobic insulin in oil formulation in this experiment. A buffer containing 10 mmol/ml Tris-HCl plus 10% acetonitrile (ACN) at pH 8.2 was used for running buffer. Samples and tested samples were successfully separated during 8 min with a good linear range(r>0.99) and a concentration detection limit of 0.01 mg/ml. Furthermore, quantitative determinations of insulin in oil formulation had been described and assessed after handled with different pre-treatment conditions to reveal the effect of pH, temperature and tryptic digestion.

Chemistry, Pharmaceutical↗

Differential pulse polarographic determination of clotrimazole after derivatization with Procion Red HE-3B.

Clotrimazole was shown to react at room temperature in Britton Robinson buffer pH 2 with the reactive dye Procion Red HE-3B. The product exhibited a differential pulse polarographic peak at -0.38 V, which was well separated from the peaks of the reactive dye at -0.08, -0.80 and -0.95 V, and this allowed the indirect determination of clotrimazole in the presence of excess of the reactive dye. The method has been applied satisfactorily to the determination of clotrimazole in pharmaceutical formulations, calibration graphs are rectilinear up to at least 40 microg ml(-1). The detection limit was calculated to be 2.6 microg ml(-1) (3 sigma).

Chemistry, Pharmaceutical↗